Clinical trial
Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Clobazam in Patients With Lennox-Gastaut Syndrome
NCT00518713 is registered in ClinicalTrials.gov with Lundbeck LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Clobazam in Patients With Lennox-Gastaut Syndrome
- Lead sponsor
- Lundbeck LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2007
- Completion date
- April 30, 2010
- Enrollment
- 238 (actual)
- Sites
- 53
Conditions
As the registry lists them; a condition with its own page is linked.